Randomized, Double Bilnd, Controlled, Parallel-Group, Multicenter Study of a Subcutaneous Formulation of Icatbant vs. oral Tranexamic Acid for the Treatment of Hereditary Angioedema (HAE)
- Conditions
- Hereditary Angioedema (HAE)MedDRA version: 9.1Level: LLTClassification code 10019860Term: Hereditary angioedema
- Registration Number
- EUCTR2004-001540-71-IT
- Lead Sponsor
- JERINI AG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method